01513.HK
Livzon Pharmaceutical Group, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 20.40
−1.16%Margins
Gross margin
63.3%
EBITDA margin
25.3%
EBIT margin
21.4%
Net margin
15.6%
FCF margin
27.1%
12.5%
Return on equity
7.1%
Return on assets
13.0%
Return on invested capital
0.45x
Asset turnover
HKD 3.9B
Cash from operations
HKD 11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026